Cerebrospinal fluid T cell responses against glutamic acid decarboxylase 65 in patients with stiff person syndrome

Journal of Autoimmunity

Volumn 32, Issue 1, 2009, Pages 24-32

  Skorstad, Gjertrud ^a,b   Hestvik, Anne Lise K ^b   Vartdal, Frode ^b   Holmøy, Trygve ^a,b  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Cerebrospinal fluid; GAD65; Stiff person syndrome; T cell

Indexed keywords

CYSTEINE; EPITOPE; GLUTAMATE DECARBOXYLASE 65; HLA DP ANTIGEN; IMMUNOGLOBULIN G;

ADULT; ARTICLE; B LYMPHOCYTE; CASE REPORT; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID; ENZYME ACTIVITY; ENZYME SYNTHESIS; FEMALE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; IN VIVO STUDY; MALE; PRIORITY JOURNAL; STIFF MAN SYNDROME; T LYMPHOCYTE;

EID: 58849157645     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2008.10.002     Document Type: Article

References (53)

1. Butler M.H., Solimena M., Dirkx Jr. R., Hayday A., and De Camilli P. Identification of a dominant epitope of glutamic acid decarboxylase (GAD-65) recognized by autoantibodies in stiff-man syndrome. J Exp Med 178 (1993) 2097-2106
2. Dalakas M.C., Li M., Fujii M., and Jacobowitz D.M. Stiff person syndrome: quantification, specificity, and intrathecal synthesis of GAD65 antibodies. Neurology 57 (2001) 780-784
3. 2-terminal epitope in the autoantigen GAD65, distinguish stiff-man syndrome from insulin-dependent diabetes mellitus. J Exp Med 180 (1994) 595-606
4. Rakocevic G., Raju R., and Dalakas M.C. Anti-glutamic acid decarboxylase antibodies in the serum and cerebrospinal fluid of patients with stiff-person syndrome: correlation with clinical severity. Arch Neurol 61 (2004) 902-904
5. Solimena M., Folli F., Denis-Donini S., Comi G.C., Pozza G., De Camilli P., et al. Autoantibodies to glutamic acid decarboxylase in a patient with stiff-man syndrome, epilepsy, and type I diabetes mellitus. N Engl J Med 318 (1988) 1012-1020
6. Skorstad G., Hestvik A.L., Torjesen P., Alvik K., Vartdal F., Vandvik B., et al. GAD65 IgG autoantibodies in stiff person syndrome: clonality, avidity and persistence. Eur J Neurol 15 (2008) 973-980
7. Dalakas M.C., Fujii M., Li M., and McElroy B. The clinical spectrum of anti-GAD antibody-positive patients with stiff-person syndrome. Neurology 55 (2000) 1531-1535
8. Pugliese A., Gianani R., Eisenbarth G.S., De Camilli P., and Solimena M. Genetics of susceptibility and resistance to insulin-dependent diabetes in stiff-man syndrome. Lancet 344 (1994) 1027-1028
9. Costa M., Saiz A., Casamitjana R., Castaner M.F., Sanmarti A., Graus F., et al. T-cell reactivity to glutamic acid decarboxylase in stiff-man syndrome and cerebellar ataxia associated with polyendocrine autoimmunity. Clin Exp Immunol 129 (2002) 471-478
10. Hummel M., Durinovic-Bello I., Bonifacio E., Lampasona V., Endl J., Fessele S., et al. Humoral and cellular immune parameters before and during immunosuppressive therapy of a patient with stiff-man syndrome and insulin dependent diabetes mellitus. J Neurol Neurosurg Psychiatry 65 (1998) 204-208
11. Lohmann T., Hawa M., Leslie R.D., Lane R., Picard J., and Londei M. Immune reactivity to glutamic acid decarboxylase 65 in stiffman syndrome and type 1 diabetes mellitus. Lancet 356 (2000) 31-35
12. Lohmann T., Londei M., Hawa M., and Leslie R.D. Humoral and cellular autoimmune responses in stiff person syndrome. Ann NY Acad Sci 998 (2003) 215-222
13. Schloot N.C., Batstra M.C., Duinkerken G., De Vries R.R., Dyrberg T., Chaudhuri A., et al. GAD65-reactive T cells in a non-diabetic stiff-man syndrome patient. J Autoimmun 12 (1999) 289-296
14. Hickey W.F., Hsu B.L., and Kimura H. T-lymphocyte entry into the central nervous system. J Neurosci Res 28 (1991) 254-260
15. Skulina C., Schmidt S., Dornmair K., Babbe H., Roers A., Rajewsky K., et al. Multiple sclerosis: brain-infiltrating CD8+ T cells persist as clonal expansions in the cerebrospinal fluid and blood. Proc Natl Acad Sci U S A 101 (2004) 2428-2433
16. Nepom G.T., Lippolis J.D., White F.M., Masewicz S., Marto J.A., Herman A., et al. Identification and modulation of a naturally processed T cell epitope from the diabetes-associated autoantigen human glutamic acid decarboxylase 65 (hGAD65). Proc Natl Acad Sci U S A 98 (2001) 1763-1768
17. Falk K., Rotzschke O., Stevanovic S., Jung G., and Rammensee H.G. Pool sequencing of natural HLA-DR, DQ, and DP ligands reveals detailed peptide motifs, constraints of processing, and general rules. Immunogenetics 39 (1994) 230-242
18. Laterre E.C., Callewaert A., Heremans J.F., and Sfaello Z. Electrophoretic morphology of gamma globulins in cerebrospinal fluid of multiple sclerosis and other diseases of the nervous system. Neurology 20 (1970) 982-990
19. Kinnman J., and Link H. Intrathecal production of oligoclonal IgM and IgG in CNS sarcoidosis. Acta Neurol Scand 69 (1984) 97-106
20. Winfield J.B., Shaw M., Silverman L.M., Eisenberg R.A., Wilson III H.A., and Koffler D. Intrathecal IgG synthesis and blood-brain barrier impairment in patients with systemic lupus erythematosus and central nervous system dysfunction. Am J Med 74 (1983) 837-844
21. Sharief M.K., Hentges R., and Thomas E. Significance of CSF immunoglobulins in monitoring neurologic disease activity in Behcet's disease. Neurology 41 (1991) 1398-1401
22. Ochsenbein A.F., Pinschewer D.D., Sierro S., Horvath E., Hengartner H., and Zinkernagel R.M. Protective long-term antibody memory by antigen-driven and T help-dependent differentiation of long-lived memory B cells to short-lived plasma cells independent of secondary lymphoid organs. Proc Natl Acad Sci U S A 97 (2000) 13263-13268
23. Bernasconi N.L., Traggiai E., and Lanzavecchia A. Maintenance of serological memory by polyclonal activation of human memory B cells. Science 298 (2002) 2199-2202
24. Hoyer B.F., Moser K., Hauser A.E., Peddinghaus A., Voigt C., Eilat D., et al. Short-lived plasmablasts and long-lived plasma cells contribute to chronic humoral autoimmunity in NZB/W mice. J Exp Med 199 (2004) 1577-1584
25. Meinl E., Krumbholz M., and Hohlfeld R. B lineage cells in the inflammatory central nervous system environment: migration, maintenance, local antibody production, and therapeutic modulation. Ann Neurol 59 (2006) 880-892
26. Winges K.M., Gilden D.H., Bennett J.L., Yu X., Ritchie A.M., and Owens G.P. Analysis of multiple sclerosis cerebrospinal fluid reveals a continuum of clonally related antibody-secreting cells that are predominantly plasma blasts. J Neuroimmunol 192 (2007) 226-234
27. Ota K., Matsui M., Milford E.L., Mackin G.A., Weiner H.L., and Hafler D.A. T-cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis. Nature 346 (1990) 183-187
28. Burns J., Rosenzweig A., Zweiman B., and Lisak R.P. Isolation of myelin basic protein-reactive T-cell lines from normal human blood. Cell Immunol 81 (1983) 435-440
29. Jingwu Z., Medaer R., Hashim G.A., Chin Y., van den Berg-Loonen E., and Raus J.C. Myelin basic protein-specific T lymphocytes in multiple sclerosis and controls: precursor frequency, fine specificity, and cytotoxicity. Ann Neurol 32 (1992) 330-338
30. Berthelot L., Laplaud D.A., Pettre S., Ballet C., Michel L., Hillion S., et al. Blood CD8+ T cell responses against myelin determinants in multiple sclerosis and healthy individuals. Eur J Immunol 38 (2008) 1889-1899
31. Allegretta M., Nicklas J.A., Sriram S., and Albertini R.J. T cells responsive to myelin basic protein in patients with multiple sclerosis. Science 247 (1990) 718-721
32. Olsson T., Zhi W.W., Hojeberg B., Kostulas V., Jiang Y.P., Anderson G., et al. Autoreactive T lymphocytes in multiple sclerosis determined by antigen-induced secretion of interferon-gamma. J Clin Invest 86 (1990) 981-985
33. Monti P., Sciropli M., Rigamonti A., Mayr A., Jaeger A., Bonfanti R., et al. Evidence for in vivo primed and expanded autoreactive T cells as a specific feature of patients with type 1 diabetes. J Immunol 179 (2007) 5785-5792
34. Shimoda S., Miyakawa H., Nakamura M., Ishibashi H., Kikuchi K., and Kita H. CD4 T-cell autoreactivity to the mitochondrial autoantigen PDC-E2 in AMA-negative primary biliary cirrhosis. J Autoimmunol 31 (2008) 110-115
35. Zhang J., Markovic-Plese S., Lacet B., Raus J., Weiner H.L., and Hafler D.A. Increased frequency of interleukin 2-responsive T cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis. J Exp Med 179 (1994) 973-984
36. Raju R., and Hampe C.S. Immunobiology of stiff-person syndrome. Int Rev Immunol 27 (2008) 79-92
37. Hiemstra H.S., Schloot N.C., van Veelen P.A., Willemen S.J., Franken K.L., van Rood J.J., et al. Cytomegalovirus in autoimmunity: T cell crossreactivity to viral antigen and autoantigen glutamic acid decarboxylase. Proc Natl Acad Sci U S A 98 (2001) 3988-3991
38. Hassin-Baer S., Kirson E.D., Shulman L., Buchman A.S., Bin H., Hindiyeh M., et al. Stiff-person syndrome following West Nile fever. Arch Neurol 61 (2004) 938-941
39. Becher B., Bechmann I., and Greter M. Antigen presentation in autoimmunity and CNS inflammation: how T lymphocytes recognize the brain. J Mol Med 84 (2006) 532-543
40. Jaume J.C., Parry S.L., Madec A.M., Sonderstrup G., and Baekkeskov S. Suppressive effect of glutamic acid decarboxylase 65-specific autoimmune B lymphocytes on processing of T cell determinants located within the antibody epitope. J Immunol 169 (2002) 665-672
41. Ishizawa K., Komori T., Okayama K., Qin X., Kaneko K., Sasaki S., et al. Large motor neuron involvement in Stiff-man syndrome: a qualitative and quantitative study. Acta Neuropathol 97 (1999) 63-70
42. Kasperek S., and Zebrowski S. Stiff-man syndrome and encephalomyelitis. Report of a case. Arch Neurol 24 (1971) 22-30
43. Meinck H.M., and Thompson P.D. Stiff man syndrome and related conditions. Mov Disord 17 (2002) 853-866
44. Mitsumoto H., Schwartzman M.J., Estes M.L., Chou S.M., La Franchise E.F., De Camilli P., et al. Sudden death and paroxysmal autonomic dysfunction in stiff-man syndrome. J Neurol 238 (1991) 91-96
45. Nakamura N., Fujiya S., Yahara O., Fujioka Y., and Kawakami Y. Stiff-man syndrome with spinal cord lesion. Clin Neuropathol 5 (1986) 40-46
46. Warren J.D., Scott G., Blumbergs P.C., and Thompson P.D. Pathological evidence of encephalomyelitis in the stiff man syndrome with anti-GAD antibodies. J Clin Neurosci 9 (2002) 328-329
47. Martinelli P., Pazzaglia P., Montagna P., Coccagna G., Rizzuto N., and Simonati S. et el. Stiff-man syndrome associated with nocturnal myoclonus and epilepsy. J Neurol Neurosurg Psychiatry 41 (1978) 458-462
48. Saiz A., Minguez A., Graus F., Marin C., Tolosa E., and Cruz-Sanchez F. Stiff-man syndrome with vacuolar degeneration of anterior horn motor neurons. J Neurol 246 (1999) 858-860
49. Warich-Kirches M., Von Bossanyi P., Treuheit T., Kirches E., Dietzmann K., Feistner H., et al. Stiff-man syndrome: possible autoimmune etiology targeted against GABA-ergic cells. Clin Neuropathol 16 (1997) 214-219
50. Wei J., and Wu J.Y. Structural and functional analysis of cysteine residues in human glutamate decarboxylase 65 (GAD65) and GAD67. J Neurochem 93 (2005) 624-633
51. Li P., Haque M.A., and Blum J.S. Role of disulfide bonds in regulating antigen processing and epitope selection. J Immunol 169 (2002) 2444-2450
52. Maric M., Arunachalam B., Phan U.T., Dong C., Garrett W.S., Cannon K.S., et al. Defective antigen processing in GILT-free mice. Science 294 (2001) 1361-1365
53. Battaglioli G., Liu H., Hauer C.R., and Martin D.L. Glutamate decarboxylase: loss of N-terminal segment does not affect homodimerization and detection of the oxidation state of cysteine residues. Neurochem Res 30 (2005) 989-1001